IL2 and Seizure: After treatment, the total effective rates of the control group and the treatment group were 80.95% and 95.24%, respectively. The HAD scores of both groups were significantly reduced, while MoCA was significantly increased. The number of epileptic seizures in both groups of patients was significantly lower than before treatment, and the serum levels of IL-2 and TNF-α in both groups of patients were significantly lower; the reduction of the above indicators in the treatment group was better than that in the control group